Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Confusion Reigns (Or What to Do When Nothing Makes Sense)

As I reach end-of-week, end-of-month book-squaring, where all of my urgent e-mails and all of my myopic missives and all of my topical tweets are summarized in once terse and quite concise "Monthly P&L," I am astounded at the most recent example of how masterfully the Gol...

Analyst Increases Target Price on 'Top Lithium Exploration Pick'

The rationale for the upgrade to the name and its elevated status are laid out in a Canaccord Genuity report. Source: Neo Lithium Corp. In an April 22 research note, analyst Eric Zaunscherb reported that Canaccord Genuity raised its target pr...

Maple Gold for US$6 an Ounce and I Was Wrong About an October Crash

I just hate it when I have to admit that I was dead wrong about something as important as calling for a major crash in October. Perhaps a little whining would make it go down easier. Something very bad comes this way. Right out of the blue the Fed began to dump bundl...

Immuno-Oncology Firm Expands Agreement with AbbVie

The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report. In a Nov. 21 research note, ROTH Capital Partners analyst Zegbeh Jallah reported that Harpoon Therapeutics Inc. (HARP:NASDAQ) and AbbVie Inc. (ABBV...

Buzz on the Bullboards: Stocks making news as markets hit new highs

The past week has been eventful for North American stock markets, with the TSX and Dow Jones closing at fresh highs. However, equities in Toronto gave up some of their gains, reflecting a mixed sentiment among investors. Among the standout performers in Canada, three ...

The Die Is Cast

One of my good friends from the 1980s and 1990s was the late Ian McAvity, a superb technical analyst, a founder of Central Fund of Canada, a Bay Street Mover and, most importantly, a humble and thoroughly enjoyable man. He was the first newsletter writer that I came acros...

Oil & Gas Explorer Proves Up Exciting Measured Oil and Gas Production from Orogrande Basin Project

Discovering a new oil field is a major accomplishment. But effectively producing hydrocarbons from that field is seen as a truly exceptional, massive success. As you can probably imagine, it's a rare occurrence. So, when a small oil and gas exploration company reaches...

Exclusive CEO Interview, Thomas Ullrich, Aston Bay [BAY.v]

I’ve been watching this Company for nearly 2 years. There have been ups and downs, a lot of excitement and some disappointments, but the management team at Aston Bay Holdings (TSX-V: BAY) (OTCQB: ATBHF) is superb, no one can argue that fact. And, the market f...

God Bless Winston

"'Success consists of going from failure to failure without loss of enthusiasm." - Sir Winston Churchill Throughout history, society has always canonized certain political, military, and religious icons for reasons seemingly obvious, but after drilling down into the fa...

Scottie Resources, a Golden Triangle Gold Junior, Reports Blockbuster Drill Results

Strong drill results have confirmed and expanded the Bend Vein target on Scottie Resources Corp.'s (SCOT:TSX.V) 100%-controlled Bow property. During September, the company completed 878 meters of diamond drilling, 2 km NE of the 100%-owned past-producing Scottie Gold ...
1 2 3 4 5 6 7 8 9 10 ...